KARKUCAK, M. Et Al. 2021. Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks. ARCHIVES OF RHEUMATOLOGY , vol.36, no.1 , 56-62.

KARKUCAK, M., KOLA, M., Kalkisim, A., ÇAPKIN, E., AYAR, A., & TÜRK, A., (2021). Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks. ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, 56-62.

KARKUCAK, MURAT Et Al. "Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks," ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, 56-62, 2021

KARKUCAK, MURAT Et Al. "Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks." ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, pp.56-62, 2021

KARKUCAK, M. Et Al. (2021) . "Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks." ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, pp.56-62.

@article{article, author={MURAT KARKUCAK Et Al. }, title={Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks}, journal={ARCHIVES OF RHEUMATOLOGY}, year=2021, pages={56-62} }